Cancer survival markers in effusions of advanced ovarian carcinoma.
- Prosjektnummer
- 2010024
- Ansvarlig person
- Ben Davidson
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Korttidsstipend, for fullføring av dr. grad
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.
Hum Pathol 2012 Apr;43(4):496-505. Epub 2011 aug 19
PMID: 21855111
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.
Cancer 2012 Mar;118(6):1543-53. Epub 2011 aug 25
PMID: 22009736
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.
Cancer Chemother Pharmacol 2012 May;69(5):1307-14.
PMID: 22302409 - Inngår i doktorgradsavhandlingen
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases.
Virchows Arch 2012 May;460(5):505-13. Epub 2012 apr 4
PMID: 22476403 - Inngår i doktorgradsavhandlingen
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
Hum Pathol 2012 Nov;43(11):2062-9. Epub 2012 mai 29
PMID: 22647351
MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.
Gynecol Oncol 2012 Sep;126(3):460-5. Epub 2012 mai 28
PMID: 22652154 - Inngår i doktorgradsavhandlingen
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance.
Hum Pathol 2013 May;44(5):777-85. Epub 2012 okt 29
PMID: 23114921 - Inngår i doktorgradsavhandlingen
Class III ß-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
Hum Pathol 2011 Jul;42(7):1019-26. Epub 2011 feb 11
PMID: 21315408
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma.
Hum Pathol 2010 Jun;41(6):794-804. Epub 2010 feb 12
PMID: 20153512
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport